Antibody treatment of hepatocellular carcinoma: a review of current and emerging approaches

Antibody treatment of hepatocellular carcinoma: a review of current and emerging approaches

Hepatocellular carcinoma (HCC) remains a leading cause of cancer-related deaths worldwide, underscoring the urgent need for innovative therapeutic strategies. Antibody-based therapies have emerged as a transformative approach, offering specificity and the potential to overcome the limitations of tra...

Full description

Saved in:
Bibliographic Details
Main Authors: Sherif A. El-Kafrawy, Mostafa S. Elkafrawy, Esam I. Azhar, Anwaar Saeed, Ashraf A. Tabll
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Immunology
Subjects:
HCC
antibody therapy
monoclonal antibodies
bispecific antibodies
antibody-drug conjugates
immune checkpoints inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2025.1533874/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2025.1533874/full

Similar Items